CD274 and liver cancer: However, a meta-analysis of three randomized phase III clinical trials that tested inhibitors of PD-L1 or PD1 in more than 1600 patients with advanced liver cancer revealed that immunotherapy did not improve survival in patients with non viral liver cancer [77].